Form 8-K - Current report:
SEC Accession No. 0001104659-25-058900
Filing Date
2025-06-12
Accepted
2025-06-12 16:20:12
Documents
12
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517792d2_8k.htm   iXBRL 8-K 69732
  Complete submission text file 0001104659-25-058900.txt   238705

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ogn-20250610.xsd EX-101.SCH 3008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20250610_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20250610_pre.xml EX-101.PRE 22355
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517792d2_8k_htm.xml XML 3684
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 251042929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)